Hour 3 - Dr. Judy Mikovits, PhD (molecular biologist) provides an update on CDC corrpution, retrovirus, Theranos
Dr. Judy Mikovits, PhD
Judy testified on a lawsuit for Racketeering and conspiracy against the CA legislators who passed the SB277 mandating toxins be inoculated in their children under the guise of vaccination and she will re-cap her testimony...
Other references and webpages:
Judy's previous interviews on the Declare Your Independence with Ernest Hancock Radio Show: https://www.freedomsphoenix.com/Guest-Page.htm?No=01359
Judy A. Mikovits, PhD has spent her life training to be a research scientist to honor her grandfather who died of cancer when she was a teenager. Dr. Mikovits earned her BA from University of Virginia and PhD in Biochemistry and Molecular Biology from George Washington University. In her 35-year quest to understand and treat chronic diseases, she has studied immunology, natural products chemistry, epigenetics, virology and drug development. In just over twenty years she rose from an entry-level lab technician to become director of the lab of Antiviral Drug Mechanisms at the National Cancer Institute before leaving to direct the Cancer Biology program at EpiGenX Pharmaceuticals in Santa Barbara, California where she had met and married David Nolde in 2000. There in 2006, she became attracted to the plight of patients with Chronic Fatigue Syndrome and Autism. In only five years she developed the first neuroimmune institute from a concept to a reality and is primarily responsible for demonstrating the relationship between immune based inflammation and these diseases. She has published over 50 scientific papers.
Dr. Judy A. Mikovits recently founded MAR Consulting Inc. with her collaborator Dr. Frank Ruscetti.
She can be contacted at:
MAR Consulting Inc.
300 Carlsbad Village Drive
Suite 108A Box 132
Carlsbad, CA 92008or
MAR Consulting Inc. website:
MAR Consulting Inc., led by Drs. Frank Ruscetti and Judy A. Mikovits, seeks to understand complex and innovative biological issues to yield unbiased integrated, cutting-edge information for patients and physicians impacted by some of the most challenging chronic diseases. Utilizing their combined 75 years experience in tumor biology, immunobiology of retroviral-associated inflammatory diseases, cancer, stem cell biology, hematopoiesis, and drug development, MAR focuses on research projects, consulting (to patients doctors, academia, and industry) and lecturing without the restrictive authority of vested interest groups, following Thomas Jefferson's dictum: "Here we are not afraid to follow the truth wherever it may lead, nor to tolerate error so long as freedom is left free to combat it."
On July 22, 2009, a special meeting was held with twenty-four leading scientists at the National Institutes of Health to discuss early findings that a newly discovered retrovirus was linked to chronic fatigue syndrome (CFS), prostate cancer, lymphoma, and eventually neurodevelopmental disorders in children.
When Dr. Judy Mikovits finished her presentation the room was silent for a moment, then one of the scientists said, "Oh my God!" The resulting investigation would be like no other in science.
For Dr. Mikovits, a twenty-year veteran of the National Cancer Institute, this was the midpoint of a five-year journey that would start with the founding of the Whittemore-Peterson Institute for Neuro-Immune Disease at the University of Nevada, Reno, and end with her as a witness for ?the federal government against her former employer, Harvey Whittemore, for Illegal campaign contributions to U. S. Senate Majority Leader, Harry Reid.
On this journey Dr. Mikovits would face the scientific prejudices against CFS, wander into the minefield that is autism, and through it all struggle to maintain her faith in God and the profession to which she had dedicated her life. This is a story for anybody interested in the peril and promise of science at the very highest levels in our country.
Plague The Book: Teaser Trailer:
To order your copy of Plague: One Scientist's intrepid Search For the Truth about Human Retroviruses and Chronic Fatigue Syndrome, Autism, and Other Diseases Click on any of the links - Amazon.com Barnes & Noble.com IndieBound
TOPICS AND REFERENCES:
Colon and Rectal Cancers Rising in Young People
02-28-2017 • New York TImes
Cancers of the colon and rectum have been declining in older adults in recent decades and have always been considered rare in young people. But scientists are reporting a sharp rise in colorectal cancers in adults as young as their 20s and 30s, an ominous trend.
The vast majority of colorectal cancers are still found in older people, with nearly 90 percent of all cases diagnosed in people over 50. But a new study from the American Cancer Society that analyzed cancer incidence by birth year found that colorectal cancer rates, which had dropped steadily for people born between 1890 and 1950, have been increasing for every generation born since 1950. Experts aren't sure why.
Rectal cancers are rising particularly sharply, far faster than cancers in other parts of the large intestine or colon. The American Cancer Society estimates about 13,500 new cases of colon and rectal cancers will be diagnosed in Americans under 50 this year, with more than 95,500 cases of colon cancer and nearly 40,000 cases of rectal cancer in all age groups.
"People born in 1990, like my son, have double the risk of colon cancer and quadruple the risk of rectal cancer" compared to the risk someone born in 1950 faced at a comparable age, said Rebecca Siegel, an epidemiologist with the American Cancer Society and the lead author of the new report, published in the Journal of the National Cancer Institute on Tuesday. And though the absolute risk is still small in younger people, she said, "They carry the risk forward with them as they age."
It is the upward trend that is worrisome: The risk of colon cancer for individuals who were born in 1990 was five per million people in that birth group, up from three per million at the same stage of life for those born in 1950. And the risk of rectal cancer for those born in 1990 was four per million, up from 0.9 per million for those born in 1950.
Dr. Thomas Weber, a professor of surgery at SUNY Downstate Medical Center who has served on the National Colorectal Cancer Roundtable and who was not involved in the new study, said the latest research confirms the problem is real and increasing. "There is no mistaking these dramatic increases, especially for rectal cancers," he said, noting that the number of new colorectal cancers among people under 50 each year exceeds the total number of new cases of less common cancers like Hodgkin's lymphoma.
Young people with colorectal cancer run the added risk of a getting a diagnosis later in the course of their disease, when the cancer may be less treatable, because doctors typically don't consider the diagnosis at such a young age. Kirsten Freiborg, who is now 27, complained to doctors repeatedly about having blood in her stool when she was in college, but was told she had internal hemorrhoids. She was finally given a diagnosis of advanced colon cancer a month before her graduation, when she was 22.
Ms. Freiborg's mother, a registered nurse, "kept pushing" for more testing, Ms. Freiborg said, and eventually convinced physicians to send her for a procedure called a flexible sigmoidoscopy, which detected a large tumor in Ms. Freiborg's colon.
Tara Anderson, 40, of Bowie, Md., was given a diagnosis of colon cancer when she was 38 years old.CreditJustin T. Gellerson for The New York Times
"I still remember getting the phone call from the doctor who did the procedure, who was completely shocked, and said 'I would never have guessed that a 22-year-old would have had cancer,'" said Ms. Freiborg, who was treated with surgery and chemotherapy and is now cancer-free.
Read Full Story